Fenwick & West has represented Nava Benefits. Alliant Insurance Services has entered into an agreement to acquire Nava Benefits, a provider of employee benefits brokerage services....
Alliant Insurance Services to Acquire Nava Benefits
iRhythm to Acquire VitalConnect in $287.5 Million Digital Health Deal
Fenwick & West has advised iRhythm Holdings. Goodwin Procter has advised VitalConnect. iRhythm Holdings, Inc. (Nasdaq: IRTC), a digital healthcare company specializing in solutions for disease...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Incyte to Acquire Vega Therapeutics from Star Therapeutics for Up to $2 Billion
Fenwick & West has advised Star Therapeutics on the transaction, while Goodwin Procter has advised Incyte. Star Therapeutics and Incyte have announced a definitive agreement in...
Merger Agreement Between Treeline Biosciences and Standard BioTools
Freshfields LLP and Richards, Layton & Finger, P.A. have advised Standard BioTools. Fenwick & West LLP has represented Treeline Biosciences. Treeline Biosciences and Standard BioTools Inc....
Halozyme Acquires Surf Bio in $400 Million Deal to Expand Drug Delivery Capabilities
Fenwick & West has advised Surf Bio on the deal. Surf Bio, a biopharmaceutical company specializing in innovative drug delivery technologies, has been acquired by Halozyme...
CorMedix Acquires Melinta Therapeutics in $300 Million Deal
Fenwick & West LLP has advised Melinta Therapeutics on the transaction, and Katten Muchin Rosenman LLP has advised Deerfield Management Company, L.P. Melinta Therapeutics, a commercial-stage...
ACELYRIN’s Merger with Alumis
Fenwick & West and Paul Hastings advised ACELYRIN, INC. on the transaction, and Cooley advised Alumis Inc. ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company...
Eli Lilly’s $3.2 Billion Acquisition of Morphic Holdings
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
Johnson & Johnson’s $13.1 Billion Acquisition of Shockwave Medical
Freshfields Bruckhaus Deringer is representing Johnson & Johnson in the transaction, and Fenwick & West is representing Shockwave Medical. Johnson & Johnson (NYSE: JNJ) and Shockwave Medical,...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Insight Enterprises’ Acquisition of SADA
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...